Adrian Ting

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Molecular Biology, Microbiology Biology
Google:
"Adrian Ting"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Taft J, Markson M, Legarda D, et al. (2021) Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death. Cell
Xu X, Kalac M, Markson M, et al. (2020) Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL). Cell Death & Disease. 11: 94
Ang RL, Chan M, Ting AT. (2019) Ripoptocide - A Spark for Inflammation. Frontiers in Cell and Developmental Biology. 7: 163
Xu X, Kalac M, Markson M, et al. (2018) Constitutive Phosphorylation of CYLD Promotes ATLL Survival By Inhibiting RIPK1-Dependent Cell Death Blood. 132: 1581-1581
Ting AT, Bertrand MJ. (2016) More to Life than NF-κB in TNFR1 Signaling. Trends in Immunology
Justus SJ, Ting AT. (2015) Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1. Immunological Reviews. 266: 145-60
O'Donnell MA, Hase H, Legarda D, et al. (2012) NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1. Plos One. 7: e41238
O'Donnell MA, Ting AT. (2012) NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death. Immunologic Research. 54: 214-26
Legarda-Addison D, Hase H, O'Donnell MA, et al. (2009) NEMO/IKKgamma regulates an early NF-kappaB-independent cell-death checkpoint during TNF signaling. Cell Death and Differentiation. 16: 1279-88
Friedman CS, O'Donnell MA, Legarda-Addison D, et al. (2008) The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. Embo Reports. 9: 930-6
See more...